Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: With the advent of sodium glucose co-transporter 2 inhibitors to control glucose and treat diabetes, laboratory data aided by either timed or spot glucose levels in the urine could be used as an alternative marker of drug response. The aim of this study was to assess the agreement between overnight urinary glucose excretion (UGE) and morning spot urinary glucose-to-creatinine ratio (UGCR). Methods: In this prospective cross-sectional study, we enrolled a total of 215 participants with either normal glucose tolerance (NGT), pre-diabetes, or type 2 diabetes mellitus (T2DM). To exclude external factors such as food intake and physical activity, urine samples collected overnight at an 8-hr interval and the first-voided morning spot urine were collected and compared. Results: The median values of overnight 8-hr UGE in participants with NGT (N=14), pre-diabetes (N=41), and T2DM (N=160) were 35.0 mg, 35.6 mg, and 653.4 mg, respectively. In participants with T2DM, the median values of overnight 8-hr UGCR and first-voided morning spot UGCR (M-UGCR) were 1.37 mg/mg and 0.16 mg/mg, respectively. Quantitative analyses using an intraclass correlation coefficient (ICC) demonstrated a good reliability of measurement of the overnight 8-hr UGCR and M-UGCR (ICC=0.943, P<0.001). The M-UGCR was also significantly related to the overnight 8-hr UGE (r=0.828, P<0.001). Conclusions: M-UGCR and overnight 8-hr UGCR showed good agreement, suggesting that M-UGCR be used as a simple index for estimating overnight amounts of UGE in patients with T2DM.
Abstract
Background: With the advent of sodium glucose co-transporter 2 inhibitors to control glucose and treat diabetes, laboratory data aided by either timed or spot glucose levels in the urine could be used as an alternative marker of drug response. The aim of this study was to assess the agreement between overnight urinary glucose excretion (UGE) and morning spot urinary glucose-to-creatinine ratio (UGCR). Methods: In this prospective cross-sectional study, we enrolled a total of 215 participants with either normal glucose tolerance (NGT), pre-diabetes, or type 2 diabetes mellitus (T2DM). To exclude external factors such as food intake and physical activity, urine samples collected overnight at an 8-hr interval and the first-voided morning spot urine were collected and compared. Results: The median values of overnight 8-hr UGE in participants with NGT (N=14), pre-diabetes (N=41), and T2DM (N=160) were 35.0 mg, 35.6 mg, and 653.4 mg, respectively. In participants with T2DM, the median values of overnight 8-hr UGCR and first-voided morning spot UGCR (M-UGCR) were 1.37 mg/mg and 0.16 mg/mg, respectively. Quantitative analyses using an intraclass correlation coefficient (ICC) demonstrated a good reliability of measurement of the overnight 8-hr UGCR and M-UGCR (ICC=0.943, P<0.001). The M-UGCR was also significantly related to the overnight 8-hr UGE (r=0.828, P<0.001). Conclusions: M-UGCR and overnight 8-hr UGCR showed good agreement, suggesting that M-UGCR be used as a simple index for estimating overnight amounts of UGE in patients with T2DM.
참고문헌 (24)
- Aires I, "Determination of the renal threshold for glucose excretion in familial renal glucosuria", Nephron, 129, pp.300~304 (2015)
- Tuvemo T, "Reevaluation of home urine glucose measurements in diabetic children. A computerized study of short-term control variables in the prediction of long-term diabetic control", Ups J Med Sci, 89, pp.244~253 (1984)
- Kverneland A, "Evaluation of blood glucose determination and 24-hour urinary glucose excretion as indicators of mean blood glucose as expressed by HbA1c in patients with insulin-dependent diabetes mellitus", Ugeskr Laeger, 148, pp.1899~1901 (1986)
- 김정민, "Glycated Hemoglobin Value for Fasting Plasma Glucose of 126 mg", dL in Korean: The 2011 Korea National Health and Nutrition Examination Survey, 2014, pp.38(6), 480~483[DOI]
- 정창희, "A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor", Diabetes and Metabolism Journal, 38(4), pp.261~273 (2014), 대한당뇨병학회[DOI]
- List JF, "Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes", Diabetes Care, 32, pp.650~657 (2009)
- Rosenstock J, "Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes", Diabetes Care, 35, pp.1232~1238 (2012)
- Wilding JP, "The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors", Metabolism, 63, pp.1228~1237 (2014)
- Lee YH, "Inverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetes", PLoS One, 9, pp.e108772~ (2014)
- Lee EY, "Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes", J Diabetes Investig, 5, pp.517~524 (2014)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
- Brown IJ, "Estimating 24-hour urinary sodium excretion from casual urinary sodium concentrations in Western populations: the INTERSALT study", Am J Epidemiol, 177, pp.1180~1192 (2013)
- Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33, pp.159~174 (1977)
- Graybill FA, "An introduction to linear statistical models. Vol 1" (1959), McGraw-Hill
- Guenther WC, "Desk calculation of probabilities for the distribution of the sample correlation coefficient", The American Statistician, 31, pp.45~48 (1977)
- Zar JH, "Biostatistical analysis" (1984), Prentice Hall
- Hayford JT, "Validity of urine glucose measurements for estimating plasma glucose concentration", Diabetes Care, 6, pp.40~44 (1983)
- Wolf S, "Renal glucose excretion and tubular reabsorption rate related to blood glucose in subjects with type 2 diabetes with a critical reappraisal of the “renal glucose threshold” model", Horm Metab Res, 41, pp.600~604 (2009)
- Walford S, "The influence of renal threshold on the interpretation of urine tests for glucose in diabetic patients", Diabetes Care, 3, pp.672~674 (1980)
- 김수경, "Effectiveness of 3-Day Continuous Glucose Monitoring for Improving Glucose Control in Type 2 Diabetic Patients in Clinical Practice", Diabetes and Metabolism Journal, 38(6), pp.449~455 (2014), 대한당뇨병학회[DOI]
- Suh S, "Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control", Diabetes Metab, 40, pp.272~277 (2014)
- Baek JH, "Efficacy of mitiglinide and sitagliptin, alone or in combination, on postprandial excursion and glycemic variability assessed by continuous glucose monitoring: a post hoc analysis with single-day treatment", Expert Opin Pharmacother, 16, pp.1127~1136 (2015)
- 이승원, "Parameters Measuring Beta-Cell Function Are Only Valuable in Diabetic Subjects with Low Body Mass Index, High Blood Glucose Level, or Long-Standing Diabetes", Yonsei Medical Journal, 52(6), pp.939~947 (2011), 연세대학교의과대학
- Polidori D, "Validation of a novel method for determining the renal threshold for glucose excretion in untreated and canagliflozin-treated subjects with type 2 diabetes mellitus", J Clin Endocrinol Metab, 98, pp.E867~E871 (2013)